1 |
Ryu JS, Ryu HJ, Lee SN, et al. Prognostic impact of minimal pleural effusion in non-small-cell lung cancer [J]. J Clin Oncol, 2014, 32(9): 960-967.
|
2 |
Verma A, Dagaonkar RS, Marshall D, et al. Differentiating malignant from tubercular pleural effusion by cancer ratio plus (cancer ratio: pleural lymphocyte count) [J]. Can Respir J, 2016, 2016: 7348239.
|
3 |
Light RW. Update on tuberculous pleurai effusion [J]. Respirology, 2010, 15(3): 451-458.
|
4 |
Farhana A, Ghosh CK, Rehena Z, et al. Comparative study of adenosine deaminase and other conventional diagnostic parameters in diagnosis of tuberculous pleural effusion [J]. Mymensingh Med J, 2015, 24(3): 550-557.
|
5 |
Zhang J, Fan YK, Wang P, et al. Cutaneous tuberculosis in China - A multicentre retrospective study of cases diagnosed between 1957 and 2013 [J]. J Eur Acad Dermatol Venereol, 2018, 2(4): 632-638.
|
6 |
Suzuki M, Matsuzuka T, Ikeda M, et al. Spontaneous regression of chemotherapy-resistant metastases from a scalp angiosarcoma [J].Fukushima J Med Sci, 2017, 63(2): 106-111.
|
7 |
Cassidy RJ, Switchenko JM, Yushak ML,et al. The importance of surgery in scalp angiosarcomas [J]. 2018, 27(4): A3-A8.
|
8 |
Vanchinathan V, Mirzamani N, Kantipudi R, et al. The vascular marker CD31 also highlights histiocytes and histiocyte-like cells within cutaneous tumors [J].Am J Clin Pathol, 2015, 143(6): 911.
|
9 |
Ajayi AA, Commins SV, Clarke DE. Metastatic angiosarcoma of the scalp presenting with cystic lung lesions: A case report and review of cystic lung diseases [J]. Perm J, 2018, 22: 17-168.
|
10 |
Hata M. Radiation therapy for angiosarcoma of the scalp: Total scalp Irradiation and local Irradiation [J]. Anticancer Res, 2018, 38(3): 1247-1253.
|
11 |
Sanada T, Nakayama H, Irisawa R, et al. Clinical outcome and dose volume evaluation in patients who undergo brachytherapy for angiosarcoma of the scalp and face [J]. Mol Clin Oncol, 2017, 6(3): 334-340.
|